Health care is among the industries that will likely be affected by the enhanced scrutiny of mergers and acquisitions, according to Michael Dashefsky, member at Bass, Berry & Sims and co-chair of the law firm’s Antitrust and Trade Practices Group. “Agencies are ramping up enforcement. They are investigating things that in the past may not have always been investigated,” Dashefsky told Hospice News. “They’re investigating things more thoroughly. They’re requiring the merging parties, typically, to have to provide more information. They’re asking questions that maybe they typically haven’t always asked.” While these changes will likely not affect transactions involving “mom-and-pop” agencies or the mid-size market, they could have an impact on proliferating “megadeals” that have occurred in the hospice and home health space.
Read the full article: How Changing Consolidation Rules Could Affect Hospice ‘Megadeals’ //